Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Thalidomide for Sjogren's Syndrome
NCT00001599Phase 2Completed
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- May 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in Sjogren's syndrome, sponsored by National Institute of Dental and Craniofacial Research. Started May 1997; status: completed.
02
Drugs
thalidomide
03
Conditions
Sjogren's syndrome
Beyond the preview
Go deeper on NCT00001599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001599.